Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Federal Trade Commission
Baxter
Teva
Queensland Health
US Army
Covington
Express Scripts
Johnson and Johnson

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020855

« Back to Dashboard

NDA 020855 describes MESNEX, which is a drug marketed by Baxter Hlthcare and is included in two NDAs. It is available from one supplier. Additional details are available on the MESNEX profile page.

The generic ingredient in MESNEX is mesna. There are ten drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mesna profile page.
Summary for 020855
Tradename:MESNEX
Applicant:Baxter Hlthcare
Ingredient:mesna
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020855
Medical Subject Heading (MeSH) Categories for 020855
Suppliers and Packaging for NDA: 020855
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MESNEX mesna TABLET;ORAL 020855 NDA Baxter Healthcare Corporation 67108-3565 N 67108-3565-9

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength400MG
Approval Date:Mar 21, 2002TE:RLD:Yes

Expired US Patents for NDA 020855

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare MESNEX mesna TABLET;ORAL 020855-001 Mar 21, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare MESNEX mesna TABLET;ORAL 020855-001 Mar 21, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
McKinsey
Medtronic
Chinese Patent Office
Daiichi Sankyo
Argus Health
Express Scripts
Harvard Business School
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.